Taken together, GLP-1based and dual GLP-1/GIP agonists represent a biologically plausible and clinically feasible strategy for repurposing as adjunctive neuroprotective therapies in PD, although further preclinical and clinical studies are needed to define their optimal dosing, treatment duration, and combinational approaches to ensure sustained neuroprotection (Figure 2)
That is the biology behind fewer heart attacks, strokes and cases of type 2 diabetes
doi: 10.1038/s41591-024-03327-6 [DOI] [PubMed] [Google Scholar] 102.Heerspink HJL, Greene T, Tighiouart H, et al
PloS One 6, e25269
Women, older age groups and senior enlisted and officer groups in the Coast Guard reported a higher number of prescriptions issued
Ive injected about four or five of my friends with Ozempic because I realised I didnt wanna use it cause its silly, Handler said